ArticleNanotoxicology2021

A methodology for developing key events to advance nanomaterial-relevant adverse outcome pathways to inform risk assessment.

Sabina Halappanavar et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.